XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (6,656,942) $ (84,402)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
General and administrative expenses paid by related party 390,511
Interest income on investments held in the Trust Account (7,513,481)
Change in fair value of forward sale securities 13,196,864
Changes in operating assets and liabilities:    
Deferred offering costs 217,609 (217,609)
Prepaid expenses 271,720 2,740
Other assets (3,514)
Accrued expenses 149,811 165,031
Net cash provided by (used in) operating activities 52,578 (134,240)
Cash flows from investing activities:    
Cash deposited in the Trust Account (200,000,000)
Net cash used in investing activities (200,000,000)
Cash flows from financing activities:    
Proceeds received from initial public offering 200,000,000
Proceeds received from private placement 5,000,000
Offering costs paid (4,298,137)
Deferred offering costs paid by related party (231,756)
Proceeds from Notes payable – related party 485,504 134,240
Payment on Notes payable – related party (134,240)
Payment on Payable to related party (848,949)
Net cash provided by financing activities 199,972,422 134,240
Net change in Cash 25,000
Cash – beginning of the period
Cash – end of the period 25,000
Supplemental disclosure of non-cash activities:    
Deferred offering costs included in Accrued expenses $ 151,489